Pyrimido pyrimidinone compound and pharmaceutical composition comprising the same
Grant
US12590098B2
Kind: B2
Mar 31, 2026
Assignee
AXCESO BIOPHARMA CO., LTD.
Inventors
Young Jun Park, Sung Jun Park, Hyebin Yoo, Hyunnam Song, Si-Eun Yun, Sojin Park, Joon Woo Kim, Sung Il Yoon
Abstract
Diclosed are a pyrimido pyrimidinone compound having an effect of inhibiting PD-L1 expression, a pharmaceutical composition containing the pyrimido pyrimidinone compound as an active ingredient, and uses of the compound or composition. The pyrimido pyrimidinone compound can be effectively used for the treatment or prevention of cancer.
CPC Classifications
C07D 487/04
Filing Date
2021-09-15
Application No.
18245395
Claims
9